Article Data

  • Views 584
  • Dowloads 129

Original Research

Open Access

MPV, NLR, and platelet count: new hematologic markers in diagnosis of malignant ovarian tumor

  • E. Yilmaz1,*,
  • E.I. Coskun1
  • N. Sahin2
  • B. Ciplak1
  • K. Ekici3

1Inonu University Turgut Ozal Medical Center Obstetrics and Gynecology Department, Malatya, Turkey

2Inonu University Turgut Ozal Medical Pathology Department, Department, Malatya, Turkey

3Inonu University Turgut Ozal Medical Radiation Oncology Department, Malatya, Turkey

DOI: 10.12892/ejgo3423.2017 Vol.38,Issue 3,June 2017 pp.346-349

Published: 10 June 2017

*Corresponding Author(s): E. Yilmaz E-mail: ercanyilmazgyn@yahoo.com

Abstract

Objective: Evaluation of mean platelet volume (MPV), neutrophil to lymphocyte ratio (NLR), and platelet count in the detection of malignant and benign ovarian tumors. Material and Methods: Sixty-six patients admitted to the present clinic over three years were included in the study. Patients diagnosed with ovarian cancer were grouped into the areas of epithelial and granulosa cell tumor diagnosis. The values were compared to patients with benign cystic structure. Patients’ preoperative hematologic parameters and their values four weeks postoperatively were analyzed. Statistical analyses were performed with SPSS software. Results: MPV, NLR, and platelet count were observed at a higher rate as statistically significant in patients diagnosed with malignant ovarian cancer, compared to those with benign adnexal mass. Conclusion: The hematological parameters such as MPV, NLR, and platelet count in the detection of malignant ovarian tumors have been evaluated as useful new markers.

Keywords

Malignant; MPV; NLR; Ovarian tumors.

Cite and Share

E. Yilmaz,E.I. Coskun,N. Sahin,B. Ciplak,K. Ekici. MPV, NLR, and platelet count: new hematologic markers in diagnosis of malignant ovarian tumor. European Journal of Gynaecological Oncology. 2017. 38(3);346-349.

References

[1] Siegel R., Naishadham D., Jemal A.: “Cancer statistics”. CA Cancer J. Clin., 2013, 63, 11.

[2] Cannistra S.A.: “Cancer of the ovary”. N. Eng. J. Med., 2004, 351, 2519.

[3] De Angelis R., Sant M., Coleman M.P., Francisci S., Baili P., Pierannunzio D., et al.: “Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE−5 a population based study”. Lancet Oncol., 2014, 15, 23.

[4] Bast R.C. Jr., Feeney M., Lazarus H., Nadler L.M., Colvin R.B., Knapp R.C.: “Reactivity of a monoclonal antibody with human ovarian carcinoma”. J. Clin. Invest., 1981, 68, 1331.

[5] Chudecka-Głaz A.M.: “ROMA, an algorithm for ovarian cancer”. Clin. Chim. Acta, 2014, 440C, 143.

[6] Kim D.K., Oh S.Y., Kwon H.C., Lee S., Kwon K.A., Kim B.G.: “Clinical signifi cances of preoperative serum interleukin-6 and Creactive protein level inoperable gastric cancer”. BMC Cancer, 2009, 9, 155.

[7] Kemal Y., Demirag G., Ekiz K., Yucel I.: “Mean platelet volume could be a useful biomarker for monitoring epithelial ovarian cancer”. J. Obstet. Gynaecol., 2014, 34, 515.

[8] Falconer H., Yin L., Grönberg H., Altman D.: “Ovarian cancer risk after salpingectomy: a nationwide population-based study”. J. Natl. Cancer Inst., 2015, 107, pii: dju410.

[9] Fleming J.S., Beaugi C.R., Haviv I., Chenevix-Trench G., Tan O.L.: “Incessant ovulation, infl ammation and epithelial ovarian carcinogenesis: revisiting old hypotheses”. Mol. Cell. Endocrinol., 2006, 247, 4 .

[10] Riman T., Nilsson S., Persson I.R.: “Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies”. Acta Obstet. Gynecol. Scand., 2004, 883, 783.

[11] Mangalpally K.K., Siqueiros-Garcia A., Vaduganathan M., Dong J.F., Kleiman N.S., Guthikonda S.: “Platelet activation patterns in platelet size subpopulations: diff erential responses to aspirin in vitro”. J. Thromb. Thrombolysis, 2010, 30, 251.

[12] Kisucka J., Butterfield C.E., Duda D.G., Eichenberger S.C., Saff aripour S.,Ware J., et al.: “Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage”. Proc. Natl. Acad. Sci. U S A, 2006, 103, 855.

[13] Naina H.V., Harris S.: “Paraneoplastic thrombocytosis in ovarian cancer”. N. Engl. J. Med., 2012, 366, 1840.

[14] Tuszynski G.P., Nicosia R.F.: “The role of thrombospondin-1 in tumor progression and angiogenesis”. Bioessays, 1996, 18, 71.

[15] Chen Y.P., Chen C., Mai Z.Y., Gao J., Shen L.J., Zhao B.C., et al.: “Pretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients”. Oncol. Lett., 2015, 9, 1458.

[16] Qi Q., Geng Y., Sun M., Wang P., Chen Z.: “Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer”. Pancreatology, 2015, 15, 145.

[17] Ji W.H., Jiang Y.H., Ji Y.L., Li B., Mao W.M.: “Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy”. Dis. Esophagus, 2015, doi: 10.1111/dote.12322. [Epub ahead of print]

[18] Zhang W., Yu C., Huang B., Zhou F.L., Huang H.D., Li Q.: “Correlation between bone metastasis and thrombocytosis in pulmonary adenocarcinoma patients”. Oncol. Lett., 2015, 9, 762.

[19] Inagaki N., Kibata K., Tamaki T., Shimizu T., Nomura S.: “Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer”. Lung Cancer, 2014, 83, 97.

[20] Kokcu A., Kurtoglu E., Celik H., Tosun M., Malatyalıoglu E., Ozdemir A.Z.: “May the platelet to lymphocyte ratio be a prognostic factor for epithelial ovarian cancer?” Asian Pac. J. Cancer Prev., 2014, 15, 9781.

[21] Yildirim M.A., Seckin K.D., Togrul C., Baser E., Karsli M.F., Gungor T., Gulerman H.C.: “Roles of neutrophil/lymphocyte and platelet/lymphocyte ratios in the early diagnosis of malignant ovarian masses”. Asian Pac. J. Cancer Prev., 2014, 15, 6881.

[22] Topcu H.O., Guzel A.I., Ozer I., Kokanali M.K., Gokturk U., Muftuoglu K.H., Doganay M.: “Comparison of neutrophil/lymphocyte and platelet/ lymphocyte ratios for predicting malignant potential of suspicious ovarian masses in gynecology practice”. Asian Pac. J. Cancer Prev., 2014, 15, 6239.

[23] Oge T., Yalcin O.T., Ozalp S.S., Isikci T.: “Platelet volume as a parameter for platelet activation in patients with endometrial cancer”. J. Obstet. Gynaecol., 2013, 33, 301

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top